ArticleExperimental & molecular medicine2025

A novel DCSTAMP antagonist impedes preosteoclast fusion via modulation of RAP1B-RAC1-mediated cytoskeletal remodeling.

Zheng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.